Tag: M&A

  • Pfizer (PFE) Has Become Ridiculously Oversold

    Pfizer (PFE) Has Become Ridiculously Oversold

    Investors may want to keep an eye on Pfizer (PFE). The stock has become ridiculously oversold at double-bottom support dating back to late 2022.  RSI, MACD, and Williams’ %R are all oversold, as well.  And from a current price of $40.81, we’d like to see PFE run back to $48 initially. We also have to remember…